Hogan Lovells has advised EyePoint Pharmaceuticals, Inc. on the deal. Cowen and Guggenheim Securities acted as joint book-running managers for the offering. Among other uses, this...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here